NCT03434730 2025-04-22
Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
Clinical Trials
9 trialsNCT02767557 2023-09-22
PACTO
Herlev Hospital
Phase 2 Completed
NCT04547062 2023-04-28
Tocilam
Nantes University Hospital
Phase 1 Completed
NCT04871854 2022-11-01
Evaluating Tocilizumab for Sever COVID-19 Infection in Breast Cancer vs. Non Cancer Pateints
Beni-Suef University
Phase 2 Completed
NCT03135171 2021-09-10
Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to Trastuzumab
University of Michigan Rogel Cancer Center
Phase 1 Completed
NCT02906371 2021-07-02
Study of the Tocilizumab Optimization Timing for CART19 Associated Cytokine Release Syndrome
University of Pennsylvania
Phase 1 Completed
NCT03601611 2020-04-21
COLAR
Herlev Hospital
Phase NA Completed
NCT02778789 2019-09-26
Re-Bone
University of Erlangen-Nürnberg Medical School
Completed
NCT01637532 2016-01-26
PITCH
Leiden University Medical Center
Phase 1/2 Completed